Health
4.5
Cardiovascular drug trial fails, experts surprised by complete lack of efficacy
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateN1 BosniaLow-rated source
HealthUnknownMedium
5.1
Eli Lilly's oral GLP-1 Foundayo shows efficacy in sleep apnea, trails injectable Zepbound
Eli Lilly's oral GLP-1 drug Foundayo met primary endpoints in two Phase 3 trials for obstructive sleep apnea, but efficacy appears lower than its injectable Zepbound. This expands the therapeutic scope of GLP-1s beyond diabetes and obesity, potentially broadening market access. Uncertainty remains on regulatory approval and comparative long-term outcomes.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Score Breakdown
Mosaic Score5.1
Model confidence0.9
Significance0.5
Source credibility0.2
Intelligence Tags
Entities
United Statescountry
Related signals
8 foundHealth
6.5
FDA mandates GLP-1 labels warn of rare blindness risk NAION
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateBBC WorldUS
Health
5.8
FDA mandates vision-loss warning on weight-loss pens after rare eye disease signal
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyInfoMoneyUS
Health
5.6
FDA Adds Eye Risk Warning to GLP-1 Labels After Review of 126 Trials
Published 2 d ago2 sourcesEvidence: Reported
SeverityModerateEl EspectadorLow-rated sourceUS
Health
5.4
GLP-1 weight-loss boom risks diverting pharma focus from insulin supply, warns foundation
Published 2 d ago2 sourcesEvidence: Reported
SeverityModerateGuardian WorldLow-rated sourceNL
Health
5.2
FDA Approves Novel Stroke Drug; Warns GLP-1s May Raise Eye Condition Risk
Published 2 d ago3 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storySTAT NewsLow-rated sourceUS
Markets
5.0
Audifarma Makes First $140M Payment to Suppliers Amid Debt Restructuring
Published 23 h ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyLa RepúblicaLow-rated sourceCO
Health
4.9
FDA warns GLP-1 drugs Ozempic, Mounjaro may raise risk of serious eye condition
Published 2 d ago1 sourceEvidence: Reported
SeverityModeratePoder360Low-rated sourceUS